ACE2 and allergic disease: IL-13 downregulates the expression of the angiotensin-converting enzyme 2 (ACE2) host cell entry receptor of SARS-CoV-2 in airway epithelial cells, and decreased levels of ACE2 transcripts are associated with allergic diseases [83].